Quality of Life Research

, Volume 14, Issue 3, pp 719–734 | Cite as

Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder

  • Anne M. Rentz
  • Louis S. Matza
  • Kristina Secnik
  • Andrine Swensen
  • Dennis A. Revicki


Measuring health-related quality of life (HRQL) in children with attention-deficit/hyperactivity disorder (ADHD) in clinical trials can complement efficacy measures, offering a complete picture of the impact of disease and treatment on overall well-being. The purpose of the current study was to psychometrically validate a multidimensional, generic HRQL instrument completed by parents of children with ADHD. A total of 921 children and adolescents with ADHD participated in a clinical study of atomoxetine. Subjects’ parents completed the 50-item Child Health Questionnaire-Parent Version (CHQ-PF50) at baseline and week 10. ADHD symptoms and behavioral problems were assessed using parent and clinician rating scales. Internal consistency reliability at baseline was 0.88 for the CHQ-PF50 Psychosocial Summary Score, ranging from 0.53 to 0.91 for subscale scores. Construct validity was supported by statistically significant correlations between CHQ-PF50 psychosocial scores and parent and clinician symptom ratings. Several methods were used to determine clinically meaningful differences in patient outcomes: inter- and intra-patient mean CHQ-PF50 change scores were tested and standard error of measurement (SEM) and effect sizes were calculated. Study results indicate the CHQ-PF50 is reliable, valid, and responsive to change in ADHD symptoms, suggesting it may provide a means of assessing HRQL outcomes associated with treatments for ADHD.


Attention-deficit/hyperactivity disorder (ADHD) Child health questionnaire (CHQ) Health-related quality of life (HRQL) Psychometrics Responsiveness 



attention-deficit/hyperactivity disorder


attention-deficit/hyperactivity disorder rating scale-IV


analysis of covariance


analysis of variance


clinical global impressions-ADHD-improvement


clinical global impressions-ADHD-Severity


Child Health Questionnaire


28-item Child Health Questionnaire-Parent Version


50-item Child Health Questionnaire-Parent Version


Conners’ parent rating scale-revised: short form


diagnostic and statistical manual of mental disorders,fourth edition


health-related quality of life


Kiddie schedule for affective disorders and schizophrenia-present and lifetime version


standard deviation


standard error of measurement


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatric Association1994Diagnostic and Statistical Manual of Mental Disorders4American Psychiatric PressWashington, DCGoogle Scholar
  2. Barkley, RA 1998Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment.2Guilford PressNew YorkGoogle Scholar
  3. Hinshaw, RD, Melnick, SM 1995Peer relationship in boys with attention deficit hyperactivity disorder with and without comorbid aggression.Dev Psychopathol7627647Google Scholar
  4. Mash, EJ, Johnston, C 1982Sibling interactions of hyperactive and normal children and their relationship to reports of maternal stress and self-esteem.J Clin Child Psychol129199Google Scholar
  5. Whalen, CK, Henker, B, Dotemoto, S 1980Methylphenidate and hyperactivity: Effects on teacher behaviors.Science20812801282Google Scholar
  6. Barkley, RA, Fischer, M, Edelbrock, C,  et al. 1991The adolescent outcome of hyperactive children diagnosed by research criteria–III. Mother–child interactions, family conflicts and maternal psychopathology.J Child Psychol Psychiatry32233255Google Scholar
  7. Pastor PN, Reuben CA. Attention deficit disorder and learning disability: United States, 1997–1998. National Center for Health Statistics. Vital Health Stat 2002; 10(206).Google Scholar
  8. Barkley, RA, DuPaul, GJ, McMurray, MB 1990Comprehensive evaluating of attention deficit disorder with and without hyperactivity as defined by research criteria.J Consult Clin Psychol58775789Google Scholar
  9. Weiss, G, Hechtman, LT 1993Hyperactive Children Grown Up.2Guilford PressNew YorkGoogle Scholar
  10. Michelson, D, Faries, D, Wernicke, J,  et al. 2001Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose–response study.Pediatrics108E83PubMedGoogle Scholar
  11. Leidy, NK, Revicki, DA, Geneste, B 1999Recommendations for evalutating the validity of life claims for labeling and promotion.Value Health2113127Google Scholar
  12. Patrick, DL, Chiang, YP 2000Measurement of health outcomes in treatment effectiveness evaluations: Conceptual and methodological challenges.Med Care38II14II25Google Scholar
  13. Eiser, C, Morse, R 2001Quality-of-life measures in chronic diseases of childhood.Health Technol Assess51157Google Scholar
  14. Gerharz, EW, Eiser, C, Woodhouse, CR 2003Current approaches to assessing the quality of life in children and adolescents.BJU Int91150154Google Scholar
  15. Landgraf, JM, Abetz, L 1996Measuring health outcomes in pediatric populations: Issues in psychometrics and application.Spilker, B eds. Quality of Life and Pharmacoeconomics in Clinical Trials.2Lippincott-RavenPhiladelphiaGoogle Scholar
  16. Patrick, DL, Erickson, P 1993Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation.Oxford University PressNew YorkGoogle Scholar
  17. Revicki, DA, Osoba, D, Fairclough, D,  et al. 2000Recommendations on health-related quality of life research to support labeling and promotional claims in the United States.Qual Life Res9887900CrossRefGoogle Scholar
  18. Landgraf, JM, Abetz, L, Ware, JE 1999The CHQ User’s Manual.HealthActBostonGoogle Scholar
  19. DeVeaugh-Geiss, J, Conners, CK, Sarkis, EH,  et al. 2002GW320659 for the treatment of attention-deficit/hyperactivity disorder in children.J Am Acad Child Adolesc Psychiatry41914920CrossRefPubMedGoogle Scholar
  20. Landgraf, JM, Maunsell, E, Speechley, KN,  et al. 1998Canadian–French, German, and UK versions of the child health questionnaire: Methodology and preliminary item scaling results.Qual Life Res7433445Google Scholar
  21. Waters, E, Salmon, L, Wake, M,  et al. 2000The child health questionnaire in Australia: Reliability, validity and population means.Aust N Z J Public Health24207210Google Scholar
  22. Waters, E, Salmon, L, Wake, M 2000The parent-form child health questionnaire in Australia: Comparison of reliability, validity, structure, and norms.J Pediatr Psychol25381391Google Scholar
  23. Ruperto, N, Ravelli, A, Pistorio, A,  et al. 2001Cross-cultural adaptation and psychometric evaluation of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) in 32 countries.Review of the general methodology. Clin Exp Rheumatol19S1S9Google Scholar
  24. Guy E (ed), ECDEU Assessment Manual for Psychopharmacology. Revised ed. Rockville, MD: National Institute of Mental Health, 1976. ed. No. 217–222.Google Scholar
  25. Ghuman, JK, Ginsburg, GS, Subramaniam, G,  et al. 2001Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: Clinical evidence from a developmental disorders institution.J Am Acad Child Adolesc Psychiatry40516524Google Scholar
  26. Riggs, PD, Leon, SL, Mikulich, SK,  et al. 1998An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.J Am Acad Child Adolesc Psychiatry3712711278CrossRefPubMedGoogle Scholar
  27. Conners, CK, Casat, CD, Gualtieri, CT,  et al. 1996Bupropion hydrochloride in attention deficit disorder with hyperactivity.J Am Acad Child Adolesc Psychiatry3513141321Google Scholar
  28. Wilens, TE, Biederman, J, Abrantes, AM,  et al. 1996A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder.J Am Acad Child Adolesc Psychiatry3514851490Google Scholar
  29. DuPaul, GJ, Power, TJ, Anastopoulos, AD,  et al. 1998ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations.Guilford PressNew YorkGoogle Scholar
  30. Kadesjo, C, Kadesjo, B, Hagglof, B,  et al. 2001ADHD in Swedish 3- to 7-year-old children.J Am Acad Child Adolesc Psychiatry4010211028Google Scholar
  31. Kratochvil, CJ, Heiligenstein, JH, Dittmann, R,  et al. 2002Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial.J Am Acad Child Adolesc Psychiatry41776784Google Scholar
  32. Magnusson, P, Smari, J, Gretarsdottir, H,  et al. 1999Attention-deficit/hyperactivity symptoms in Icelandic schoolchildren: Assessment with the attention deficit/hyperactivity rating scale-IV.Scand J Psychol40301306Google Scholar
  33. Prince, JB, Wilens, TE, Biederman, J,  et al. 2000A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.J Child Adolesc Psychopharmacol10193204CrossRefPubMedGoogle Scholar
  34. Rugino, TA, Copley, TC 2001Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study.J Am Acad Child Adolesc Psychiatry40230235Google Scholar
  35. Scahill, L, Chappell, PB, Kim, YS,  et al. 2001A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.Am J Psychiatry15810671074CrossRefPubMedGoogle Scholar
  36. American Psychiatric Association.2000Diagnostic and Statistical Manual of Mental Disorders.4American Psychiatric PressWashington, DCText RevisionGoogle Scholar
  37. Revicki, DA, Rentz, AM, Dubois, D,  et al. 2003Development and validation of a patient-assessed gastroparesis symptom severity measure: The gastroparesis cardinal symptom index.Aliment Pharmacol Ther18141150CrossRefGoogle Scholar
  38. Coyne, KS, Wiklund, I, Schmier, J,  et al. 2001Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease.Aliment Pharmacol Ther18907915Google Scholar
  39. Spies, JB, Coyne, K, Guaou Guaou, N,  et al. 2002The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata.Obstet Gynecol99290300Google Scholar
  40. Guyatt, GH, Osoba, D, Wu, AW,  et al. 2002Methods to explain the clinical significance of health status measures.Mayo Clin Proc77371383Google Scholar
  41. Crosby, RD, Kolotkin, RL, Williams, GR 2003Defining clinically meaningful change in health-related quality of life.J Clin Epidemiol56395407Google Scholar
  42. Sprangers, MA, Moinpour, CM, Moynihan, TJ,  et al. 2002Assessing meaningful change in quality of life over time: A users’ guide for clinicians.Mayo Clin Proc77561571Google Scholar
  43. Kazis, LE, Anderson, JJ, Meenan, RF 1989Effect sizes for interpreting changes in health status.Med Care27S178S189Google Scholar
  44. Guyatt, G, Walter, S, Norman, G 1987Measuring change over time: Assessing the usefulness of evaluative instruments.J Chronic Dis40171178Google Scholar
  45. Wyrwich, KW, Nienaber, NA, Tierney, WM,  et al. 1999Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life.Med Care37469478Google Scholar
  46. Wyrwich, KW, Tierney, WM, Wolinsky, FD 1999Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.J Clin Epidemiol52861873Google Scholar
  47. Landgraf, JM, Rich, M, Rappaport, L 2002Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: Development and evaluation of a new tool.Arch Pediatr Adolesc Med156384391Google Scholar
  48. Garcia-Garcia, JJ, Gonzalez-Pascual, E, Pou-Fernandez, J,  et al. 2000Development of a Spanish (Castillian) version of the childhood health assessment questionnaire. Measurement of health status in children with juvenile chronic arthritis.Clin Exp Rheumatol1895102Google Scholar
  49. Nunnally, JC, Bernstein, IH 1994Psychometric Theory3McGraw-Hill, Inc.New YorkGoogle Scholar
  50. Hays, RD, Anderson, RT, Revicki, DA 1998Assessing reliability and validity of measurement in clinical trials.Staquet, MJHays, RDFayers, PM eds. Quality of Life Assessment in Clinical Trials: Methods and Practice.Oxford University PressOxfordGoogle Scholar
  51. Eiser, C, Morse, R 2001Can parents rate their child’s health-related quality of life?Results of a systematic review. Qual Life Res10347357Google Scholar
  52. Matza, LS, Swensen, AR, Flood, EM,  et al. 2004Assessment of health-related quality of life in children: Review of conceptual, methodological and regulatory issues.Value Health77992CrossRefGoogle Scholar
  53. Rebok, G, Riley, A, Forrest, C,  et al. 2001Elementary school-aged children’s reports of their health: A cognitive interviewing study.Qual Life Res105970Google Scholar
  54. Beneke, M, Rasmus, W 1992‘‘Clinical Global Impressions’’ (ECDEU): Some critical comments.Pharmacopsychiatry25171176Google Scholar
  55. Asmussen, L, Olson, LM, Grant, EN,  et al. 2000Use of the child health questionnaire in a sample of moderate and low-income inner-city children with asthma.Am J Respir Crit Care Med16212151221Google Scholar
  56. Palermo, TM, Schwartz, L, Drotar, D,  et al. 2002Parental report of health-related quality of life in children with sickle cell disease.J Behav Med25269283Google Scholar
  57. Chassany, O, Sagnier, P, Marquis, P,  et al. 2002For the European regulatory issues on quality of life assessment group. Patient-reported outcomes: The example of health-related quality of life–A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process.Drug Inform. J.36209218Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Anne M. Rentz
    • 1
  • Louis S. Matza
    • 1
  • Kristina Secnik
    • 2
  • Andrine Swensen
    • 2
  • Dennis A. Revicki
    • 1
  1. 1.Center for Health Outcomes ResearchMEDTAP InternationalBethesdaUSA
  2. 2.Eli Lilly and CompanyIndianapolisUSA

Personalised recommendations